Pharmacokinetics and Pharmacodynamics of Anthocyanins

Completed · Not applicable

Conditions studied: Gout

In brief

The purpose of the study is to establish the pharmacokinetic parameters of cherry juice concentrate and identify its potential to alter inflammatory markers in gout patients.

Key facts

Study ID

NCT03650140

Run by

Rutgers, The State University of New Jersey

People needed

10

Starts

2019-02-01

Expected to finish

2022-06-06

Last updated by the study team

2023-01-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of gout

You may not qualify if…

• Allergy to cherries or cherry products
• Any history of malignancy
• History of any pancreatic or biliary tract disease
• Significant Anemia
• History of significant renal (sCr > 1.5 mg/dL)
• Hepatic disease (liver enzymes 3 times upper limit of normal)
• Any active gastrointestinal condition
• History of large bowel resection for any reason
• Use of cherry juice concentrate or consumption of cherries within 14 days
• Personal or inherited bleeding disorders or currently on anticoagulation
• Women of childbearing age not on oral contraceptives
• Women who are pregnant or nursing

Where it is running

• Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.